Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591
Phone: (914) 847-7000Website: https://www.regeneron.com/Careers: careers.regeneron.com
Latest news
- FDA Approves First-in-class Evkeeza (evinacumab-dgnb) for Young Children with Ultra-Rare Form of High Cholesterol
22 March 2023 - Pozelimab (C5 Antibody) BLA for Treatment of Children and Adults with Ultra-rare CHAPLE Disease Accepted for FDA Priority Review
21 February 2023 - Dupixent (dupilumab) Approved by FDA as the First and Only Treatment Indicated for Prurigo Nodularis
29 September 2022 - FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
7 June 2022 - FDA Approves Dupixent (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis
20 May 2022 - U.S. FDA Extends Review of Biologics License Application for REGEN-COV® (casirivimab and imdevimab) for Treatment and Prophylaxis of COVID-19
14 April 2022 - New Phase 3 Analyses Show That a Single Dose of REGEN-COV® (casirivimab and imdevimab) Provides Long-term Protection Against COVID-19
8 November 2021 - FDA Expands Approval of Dupixent (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
20 October 2021 - FDA Accepts REGEN-COV (casirivimab and imdevimab) for Priority Review for Treatment and Prophylaxis of COVID-19
14 October 2021 - New REGEN-COV (casirivimab and imdevimab) Data Show Supportive Results in Patients Hospitalized with COVID-19
30 September 2021
Drugs Associated with Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 7 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Arcalyst
Generic name: rilonacept Drug class: interleukin inhibitors |
3 reviews | 10 / 10 |
|
Dupixent
Generic name: dupilumab Drug class: interleukin inhibitors |
325 reviews | 6.7 / 10 |
|
Evkeeza
Generic name: evinacumab Drug class: miscellaneous antihyperlipidemic agents |
||
|
Eylea
Generic name: aflibercept Drug class: anti-angiogenic ophthalmic agents |
44 reviews | 6.7 / 10 |
|
Kevzara
Generic name: sarilumab Drug class: antirheumatics, interleukin inhibitors |
18 reviews | 5.7 / 10 |
|
Libtayo
Generic name: cemiplimab Drug class: anti-PD-1 monoclonal antibodies |
2 reviews | 10 / 10 |
|
Praluent
Generic name: alirocumab Drug class: PCSK9 inhibitors |
172 reviews | 5.9 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
